Item 16. Form 10-K Summary

2K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

| --- | --- |

None.

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

NUCOR CORPORATION
By:/s/ John J. Ferriola
John J. Ferriola
Chairman, Chief Executive Officer and President
Dated: February 28, 2019

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints James D. Frias and A. Rae Eagle, or either of them, his or her attorney-in-fact, with full power of substitution and resubstitution for such person in any and all capacities, to sign any amendments to this report and to file the same, with exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that either of said attorney-in-fact, or substitute or substitutes, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.

/s/ John J. Ferriola/s/ Lloyd J. Austin III
John J. Ferriola Chairman, Chief Executive Officer and President (Principal Executive Officer)Lloyd J. Austin III Director
/s/ James D. Frias/s/ Patrick J. Dempsey
James D. Frias Chief Financial Officer, Treasurer and Executive Vice President (Principal Financial Officer)Patrick J. Dempsey Director
/s/ Michael D. Keller/s/ Victoria F. Haynes
Michael D. Keller Vice President and Corporate Controller (Principal Accounting Officer)Victoria F. Haynes Director
/s/ Christopher J. Kearney
Christopher J. Kearney Director
/s/ Laurette T. Koellner
Laurette T. Koellner Director
/s/ John H. Walker
John H. Walker Lead Director

Dated: February 28, 2019

Previous: Item 15. Exhibits and Financial Statement Schedules